PCNP, short for PEST proteolytic signal containing nuclear protein, is a crucial player in the cellular machinery responsible for protein ubiquitination and the proteasome-mediated degradation pathway. This protein lends its name from a PEST sequence, a peptide sequence rich in proline (P), glutamic acid (E), serine (S), and threonine (T), which is associated with rapid degradation of proteins. The ubiquitin-proteasome system (UPS) is an essential cellular process for maintaining protein homeostasis by removing misfolded, damaged, or unneeded proteins. PCNP is posited to have a role in the fine-tuning of this system. The expression of PCNP is widespread, evidenced by its ubiquitous presence across various tissues, with pronounced expression in the ovary and thyroid. The function of PCNP extends to its localization in the nuclear body, implicating a significant role in nuclear processes and possibly in the regulation of gene expression. Understanding the regulation of PCNP is an area of interest as it could provide insights into the dynamic balance the cell maintains in protein quality control.
Research on molecular activators that could induce the expression of PCNP is an expanding field that focuses on compounds known to interact with the UPS. Compounds such as proteasome inhibitors are considered potential inducers of PCNP expression. These inhibitors, by impeding the normal degradative function of the proteasome, may lead to an accumulation of proteins within the cell. This protein build-up could act as a signal, stimulating a compensatory response that includes the upregulation of PCNP. Such agents include MG132, Bortezomib, and Lactacystin, which are known to bind to the proteasome, thereby blocking its proteolytic activity. Additionally, stressors such as Tunicamycin and Thapsigargin, which induce endoplasmic reticulum (ER) stress and activate the unfolded protein response (UPR), may also upregulate PCNP expression as part of the cellular adaptive mechanisms. The UPR is a cellular stress response related to the ER stress, and its activation suggests a link between the stress responses and the potential elevation of proteins like PCNP that are involved in managing protein turnover. It is the intricacies of these molecular interactions and the cellular response to stress that highlight the potential regulation of PCNP expression and its role in cellular homeostasis.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Lactacystin's binding to the proteasomal catalytic core could lead to protein accumulation, potentially instigating an increase in PCNP synthesis as part of the cellular strategy to cope with proteostatic stress. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin-induced ER stress is known to activate the unfolded protein response (UPR), which may specifically induce PCNP expression to help degrade misfolded proteins accumulating in the ER. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
By depleting ER calcium stores, thapsigargin prompts a UPR that could specifically stimulate PCNP transcription as a means to enhance the cellular machinery for protein folding and degradation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine disrupts lysosomal acidification, which may lead to an upregulation of PCNP expression as a cellular response to the consequent elevation of undegraded proteins. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
As a disruptor of proteasomal activity, Withaferin A may prompt a surge in PCNP transcription as the cell seeks to replenish and enhance its proteolytic systems. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Known to hamper the proteasomal activity, Celastrol may induce the synthesis of PCNP as part of a stress response, aiming to restore homeostasis by clearing defective proteins. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $115.00 $337.00 | 3 | |
Betulinic acid could induce the expression of PCNP by imposing stress on proteasomal functions, thereby engaging a cellular defense mechanism to elevate protein degradation processes. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
By its proteasome-inhibitory action, disulfiram could stimulate PCNP production as a corrective measure to manage the heightened load of ubiquitinated substrates. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
Oprozomib's inhibition of the proteasome might trigger a targeted upregulation of PCNP, as the cell endeavors to maintain protein homeostasis under conditions of proteasome blockade. | ||||||